Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population
- PMID: 27194008
- DOI: 10.1002/ijc.30194
Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population
Abstract
Inflammation and cancer are tightly linked. This study tests the hypothesis that an inflammatory score based on plasma levels of C-reactive protein (CRP) and fibrinogen and whole blood leukocyte count is associated with risk of colorectal, lung, breast and prostate cancer. A score ranging from none through three elevated biomarkers was constructed in 84,000 individuals from the Danish general population. During a median follow-up time of 4.8 years, 4,081 incident cancers occurred. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) of incident cancer. Multifactor-adjusted HRs for colorectal cancer were 1.28 (95% CI, 1.01 to 1.62), 1.79 (95% CI, 1.41 to 2.27) and 2.18 (95% CI, 1.67 to 2.86) for individuals with elevated levels of one, two and three inflammatory biomarkers compared to individuals with none elevated biomarkers. A similar stepwise increasing risk was observed for lung and breast cancer with HRs of 3.03 (95% CI, 2.25 to 4.08) and 1.42 (95% CI, 1.11 to 1.80) for three versus none elevated biomarkers. HRs were highest within the first years of follow-up. Absolute 5-year risk of lung cancer was 7.8 (95% CI, 6.1 to 10)% among older smokers with three elevated biomarkers compared to 3.8 (95% CI, 2.6 to 5.6)% among those with none elevated biomarkers. In conclusion, simultaneously elevated CRP, fibrinogen and leukocyte count are associated with an increased risk of colorectal, lung and breast cancer. Cancer as a promoter of inflammation may be more likely to account for our findings than low-grade inflammation promoting cancer development.
Keywords: C-reactive protein; colorectal cancer; fibrinogen; inflammation; lung cancer; whole blood leukocyte count.
© 2016 UICC.
Similar articles
-
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732. JAMA. 2013. PMID: 23757083
-
Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey.Int J Oncol. 2015 Oct;47(4):1537-44. doi: 10.3892/ijo.2015.3141. Epub 2015 Aug 31. Int J Oncol. 2015. PMID: 26323323
-
Inflammatory biomarker score and cancer: A population-based prospective cohort study.BMC Cancer. 2016 Feb 10;16:80. doi: 10.1186/s12885-016-2115-6. BMC Cancer. 2016. PMID: 26860264 Free PMC article.
-
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.Crit Rev Clin Lab Sci. 2011 Jul-Aug;48(4):155-70. doi: 10.3109/10408363.2011.599831. Crit Rev Clin Lab Sci. 2011. PMID: 22035340 Review.
-
C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.Int J Cancer. 2008 Sep 1;123(5):1133-40. doi: 10.1002/ijc.23606. Int J Cancer. 2008. PMID: 18528865 Review.
Cited by
-
Research Progress of Preoperative FPR, FAR or AFR in Patients with Colorectal Cancer.Cancer Manag Res. 2021 Feb 22;13:1791-1801. doi: 10.2147/CMAR.S292605. eCollection 2021. Cancer Manag Res. 2021. PMID: 33654428 Free PMC article. Review.
-
Association Between the Use of a Mobile Health Strategy App and Biological Changes in Breast Cancer Survivors: Prospective Pre-Post Study.J Med Internet Res. 2019 Aug 14;21(8):e15062. doi: 10.2196/15062. J Med Internet Res. 2019. PMID: 31414667 Free PMC article.
-
The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study.Eur Heart J. 2019 Dec 21;40(48):3901-3909. doi: 10.1093/eurheartj/ehz587. Eur Heart J. 2019. PMID: 31504409 Free PMC article.
-
The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis.Onco Targets Ther. 2017 Sep 20;10:4645-4656. doi: 10.2147/OTT.S143154. eCollection 2017. Onco Targets Ther. 2017. PMID: 29033583 Free PMC article.
-
Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research.Int J Environ Res Public Health. 2020 Jul 28;17(15):5445. doi: 10.3390/ijerph17155445. Int J Environ Res Public Health. 2020. PMID: 32731638 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous